Navigation Links
Onyx Pharmaceuticals Reports Third Quarter 2009 Financial Results; Nexavar Global Net Sales Top $229 Million, 27% Increase Over Third Quarter 2008
Date:11/3/2009

P basis Onyx recorded net income of $21.7 million, or $0.37 per diluted share, compared with a net income of $32.1 million, or $0.57 per diluted share, for the same period in 2008.

Management Conference Call Today

Onyx will host a teleconference and webcast to provide a general business overview and discuss financial results. The event will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on November 3, 2009. The live webcast will be available at:

http://www.onyx-pharm.com/view.cfm/32/Event-Calendar

or by dialing 847-619-6547 and using the passcode 25674242. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 25674242 approximately one hour after the teleconference concludes. The replay will be available through December 3, 2009.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, is developing and marketing Nexavar(®) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in a variety of tumor types. For more information about Onyx, visit http://www.onyx-pharm.com.

Nexavar® (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals.

This news release contains "forward-looking statements" of Onyx within the meaning of the federal securities laws. These forward-looking statements include, without limitation, statements regarding sales trends and commercial activities, the timing, progress and results of clinical development
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cumberland Pharmaceuticals to Present at Lazard Healthcare Conference in New York on November 17, 2009
2. Vanda Pharmaceuticals Reports Third Quarter 2009 Results
3. Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
4. VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
5. Vanda Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 2, 2009
6. Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco
7. Positive Data from Arena Pharmaceuticals Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
8. DUSA Pharmaceuticals Named to Deloittes 2009 Technology Fast 500 List of Fastest Growing Companies in North America
9. Peregrine Pharmaceuticals Announces Implementation of 1:5 Reverse Stock Split to Take Effect October 19, 2009
10. Proteolix, Inc. to be Acquired By Onyx Pharmaceuticals
11. Amira Pharmaceuticals to Present at Montgomery Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... With the launch of the Centers for Medicare ... (NMM) tool, monitoring provider-network adequacy will take a technological ... Services, Inc.’s (AIS) Medicare Advantage News (MAN) offers in-depth ... analysis from industry experts on why CMS is moving ... NMM were announced at CMS’s recently held annual spring ...
(Date:5/27/2015)... 2015 The new http://www.carsonenergy.com ... investors should consider oil and gas investing, the substantial ... are drilled, industry news, IRA investing, definitions and acronyms, ... of knowledge and experience is now in one central ... be able to access 24 hours a day, 7 ...
(Date:5/27/2015)... 27, 2015 The Case Management ... partnership to provide CMSA's Career and Knowledge Pathways ... seeks to strengthen the case/care management workforce by ... program. The mutually beneficial agreement provides Medix, a ... of talent in the healthcare, scientific and IT ...
(Date:5/27/2015)... View, CA (PRWEB) May 27, 2015 Coco ... Valley will be able to reach for Organic Coconut Water ... Coco Libre will be available at VIP areas, artist greenrooms, ... also be available at area hotels and on festival shuttle ... a partner this year,” said Noa Elan, Director of Strategic ...
(Date:5/27/2015)... IL (PRWEB) May 27, 2015 ... of its SonarMD Platform, a first-of-its kind, ... and managing patients with chronic gastrointestinal disease. ... MD, MBA, the application allows physicians to ... through the ongoing use of electronic health ...
Breaking Medicine News(10 mins):Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2
... Most Americans aren,t aware of national recommendations, study finds, , ... public education campaigns, only one-third of Americans know about national ... day, and fewer than half meet that goal, a new ... among men, the unemployed and people born in the United ...
... Center are studying a new, minimally invasive procedure to ... patients will undergo a less complex catheter-based procedure to ... leaks backwards toward the lungs with each heart beat. ... taking part in the national EVEREST II REALISM trial, ...
... , This release is available in French ... is up to five times more prevalent in American prisons ... be strictly monitored in prison. However, once prisoners are released, ... Pant Pai an Assistant professor of Medicine and a ...
... disease, malaria afflicts 350-500 million people worldwide each year ... by Anopheles mosquitoes, the disease occurs in more than ... of the world,s population at risk. Understandably, an ... effective malaria vaccine. Yet, despite decades of research that ...
... review past practices, researchers say , TUESDAY, Sept. ... measures used during the 1918 influenza pandemic offers lessons ... fall in response to the H1N1 swine flu pandemic, ... a common and controversial strategy for controlling the spread ...
... some success in alleviating hypoplastic left heart syndrome , TUESDAY, ... heart defect may have better outcomes when surgery to repair ... the womb, Harvard University researchers say. , The condition, ... is underdeveloped and the heart cannot pump enough blood to ...
Cached Medicine News:Health News:Exercise 30 Minutes a Day? Who Knew! 2Health News:Study offers less complex, minimally invasive procedure to treat heart valve leak 2Health News:Study highlights HIV/AIDS challenge in American prison system 2Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 2Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 3Health News:Book by UCR biologist tells story of 100-year quest for elusive malaria vaccine 4Health News:1918 Flu Closings May Provide Lessons for Today 2Health News:Fetal Surgery May Treat Heart Defect 2Health News:Fetal Surgery May Treat Heart Defect 3
(Date:5/27/2015)... REDWOOD CITY, Calif. , May 27, 2015  Genomic ... Brad Cole , Chief Operating Officer and Chief Financial Officer, ... New York City on Monday, June ... access the live and subsequently archived webcast of the presentation, ... site at http://investor.genomichealth.com .  Please connect to the web ...
(Date:5/27/2015)...  Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... that Ross Taylor , vice president of business ... chief financial officer effective August 1, 2015, will present ... June 4, 2015 at 10:00 a.m. ET. The conference ... New York City . About ...
(Date:5/27/2015)... DUBLIN, Ohio , May 27, 2015 /PRNewswire/ ... present a new series of health economic outcomes ... evaluating real-world treatment patterns when developing value-based reimbursement ... , vice president and chief medical officer of ... and pharmaceutical companies alike have known for more ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3
... plc (LSE: SHP, Nasdaq: SHPGY ), the ... Atlas manufacturing facility in Lexington, Massachusetts has been recognized ... for Pharmaceutical Engineering) Facility of the Year Awards program. ... group of 26 state-of-the-art projects constructed in 11 different ...
... night,s sleep and just five minutes of daily exercise are ... That,s the prescription of Dr. Michael Carroll, M.D., inventor ... guaranteed to relieve and even heal the shoulder pain suffered ... effectiveness is reversing the cycle of rotator cuff injures that ...
Cached Medicine Technology:Shire Recognized by ISPE Facility of the Year Awards Program 2Shire Recognized by ISPE Facility of the Year Awards Program 3Novel Night Time Healing is Key to Shoulder Pain Relief From ROTATORELIEVER 2
One step Immunochromatographic Assay for the detection of Respiratory Syncytial Virus...
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Rapid, visual assay for the presumptive qualitative detection of Respiratory Syncytial Virus (RSV) directly from nasopharyngeal specimens in neonatel and pediatric patients....
... The BD Directigen EZ RSV Test utilizes ... reagent and one device for rapid RSV detection. ... a method whereby dried reagents have already ... reduced to a two-step process, with clear-cut results ...
Medicine Products: